How do I perform and interpret a penile Doppler ultrasound in a fasting adult male with erectile dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Perform and Interpret Penile Doppler Ultrasound for Erectile Dysfunction

Penile Doppler ultrasound (PDUS) should be performed using intracavernosal vasoactive injection with serial measurements during maximal erection rigidity, measuring peak systolic velocity (PSV >30 cm/s indicates normal arterial inflow) and end-diastolic velocity (EDV <5 cm/s indicates normal veno-occlusive function). 1

Indications for PDUS

PDUS is indicated in specific clinical scenarios, not as a routine test for all ED patients 2:

  • Primary ED not caused by acquired organic disease or psychogenic factors
  • Young patients with pelvic/perineal trauma who may benefit from revascularization surgery or angioplasty
  • Penile deformities requiring surgical correction (Peyronie's disease, congenital curvature)
  • Complex psychiatric or psychosexual disorders
  • Complex endocrine disorders
  • Medicolegal documentation (e.g., before penile prosthesis implantation to document end-stage ED)
  • Patient or partner request for specific diagnostic testing

Equipment and Setup

Technical Requirements 1, 3:

  • High-frequency linear transducer: 7.5-18 MHz
  • Color Doppler capability
  • Private, comfortable setting to minimize psychogenic interference
  • Vasoactive agents available (alprostadil, papaverine, phentolamine)
  • Emergency medications on hand (phenylephrine for priapism management)

Step-by-Step Procedure

1. Initial Baseline Assessment 3, 4

Scan the flaccid penis in B-mode:

  • Assess entire penile anatomy
  • Identify both corpora cavernosa
  • Locate cavernosal arteries bilaterally
  • Document any structural abnormalities (plaques, fibrosis, calcifications)

2. Intracavernosal Injection 1, 3

Critical principle: The accuracy of PDUS depends entirely on achieving complete cavernosal smooth muscle relaxation 1.

  • Inject vasoactive agent intracavernosally (typically alprostadil 10-20 mcg, or combination agents)
  • Redosing protocol is essential to optimize reliability and reproducibility 1
  • Consider audiovisual sexual stimulation (AVSS) or manual self-stimulation to reduce psychogenic inhibition 3
  • Monitor for adequate erection response using hardness scale

3. Serial Doppler Measurements 1, 3

Key technique: Perform measurements at multiple time points, scanning during the best-quality erection achieved (full hardness), not at arbitrary time intervals 3.

Measure at each assessment:

  • Peak Systolic Velocity (PSV) in both cavernosal arteries
  • End-Diastolic Velocity (EDV) in both cavernosal arteries
  • Penile rigidity (using validated hardness scale)
  • Resistance Index (RI) = (PSV - EDV)/PSV

Timing: Continue measurements until maximal rigidity is achieved or maximum safe dose of vasoactive agent is reached 1.

Interpretation of Results

Normal Hemodynamic Parameters 1, 5, 4:

Arterial Inflow (PSV):

  • Normal: >30 cm/s (indicates adequate arterial inflow)
  • Mild arterial insufficiency: 25-30 cm/s
  • Moderate-severe arterial insufficiency: <25 cm/s

Veno-occlusive Function (EDV):

  • Normal: <5 cm/s (indicates intact veno-occlusive mechanism)
  • Borderline: 5-7 cm/s
  • Veno-occlusive dysfunction: >7 cm/s

Classification of ED Based on PDUS 5, 4:

  1. Arterial insufficiency: PSV <30 cm/s with normal EDV (<5 cm/s)
  2. Veno-occlusive dysfunction: Normal PSV (>30 cm/s) with elevated EDV (>5 cm/s)
  3. Mixed arterial and venous: PSV <30 cm/s AND EDV >5 cm/s
  4. Normal hemodynamics: PSV >30 cm/s AND EDV <5 cm/s (suggests psychogenic or neurogenic ED)

Resistance Index (RI):

  • Normal: >0.75-0.80 during full erection
  • Low RI (<0.75) suggests veno-occlusive dysfunction

Critical Pitfalls to Avoid

Common Sources of Error 1, 3:

  1. Inadequate smooth muscle relaxation: The most common cause of false-positive arterial insufficiency

    • Solution: Use redosing protocol, AVSS, and assess during maximal rigidity 1
  2. Measuring at arbitrary time points rather than at peak rigidity

    • Solution: Rigidity-based assessment, not time-based 1
  3. Psychogenic inhibition causing suboptimal erection

    • Solution: Private setting, AVSS, patient self-stimulation 3
  4. Asymmetric arterial measurements: Always measure both cavernosal arteries

    • Use the higher PSV value for interpretation if asymmetric
  5. Failure to monitor for priapism: Always confirm detumescence before discharge 1

Post-Procedure Management 1

  • Evaluate for detumescence after procedure completion
  • If persistent penetration rigidity erection: administer intracavernosal phenylephrine
  • If phenylephrine fails: perform corporal aspiration
  • Patient should not leave until adequate detumescence confirmed

Integration with Clinical Management

PDUS results guide treatment decisions 2, 6:

  • Normal hemodynamics: Consider psychogenic factors, neurogenic causes, or hormonal evaluation; refer for mental health evaluation 6
  • Arterial insufficiency: PDE5 inhibitors may still be effective; consider cardiovascular risk assessment 6
  • Veno-occlusive dysfunction: May require intracavernosal injection therapy or penile prosthesis 6
  • Young patients with arterial insufficiency from trauma: Consider revascularization surgery 2

The test should be performed by trained personnel with expertise in sexual medicine, as proper technique and interpretation are critical for accurate diagnosis and appropriate patient counseling 1, 3.

Related Questions

What is penile Doppler ultrasound?
In a 21‑year‑old man with persistent semi‑erections, glans discoloration, penile numbness, and urinary hesitancy, what findings would be expected on penile Doppler ultrasound?
Can chronic systemic inflammation and gut dysbiosis cause penile numbness through small‑fiber and autonomic nerve dysfunction despite normal Doppler ultrasound and imaging, and can sensory function recover after the inflammation is treated?
How should I evaluate and manage a 57-year-old male with normal laboratory values who has had low libido and difficulty becoming aroused for six months?
In a 21-year-old man with persistent semi‑erections, glans discoloration, penile numbness, and urinary hesitancy, can the cavernous artery Doppler ultrasound be performed without pharmacologically inducing an erection?
Does continuous renal replacement therapy cause coagulopathy?
What are the possible causes of an elevated C‑reactive protein with a normal erythrocyte sedimentation rate, negative fecal calprotectin, negative celiac serology, normal routine labs, and a normal abdominal‑pelvic computed tomography scan?
Can the patient who received a ketorolac (Toradol) injection today be continued on oral ketorolac (Toradol) and what is the appropriate dosing?
What NAD‑precursor supplementation regimen do you recommend for anti‑aging in a generally healthy adult without contraindications?
What is the appropriate management for trigger thumb?
In an otherwise healthy adult with normal renal function and no penicillin allergy, is Augmentin (amoxicillin‑clavulanate) 875 mg orally twice daily for five days appropriate prophylaxis after a dog bite?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.